Now accepting Telehealth appointments. Schedule a virtual visit.

CHR in the media: March/April 2019

In late March, Lisa Rapaport interviewed Dr. Gleicher for her article on _Reuters _about the reported higher risk of cancer among children born from IVF. Dr. Gleicher pointed out that this may be a result of chromosomal instabilities related to maternal age rather than a direct effect of IVF and patients should not prematurely forego fertility treatment.

In mid-April, Dr. Gleicher was an invited participant at a roundtable discussion on genetic editing, held by Harvard Law School's Petrie-Flom CenterNew York Times ran an editorial on the issue, arguing that mitochondrial replacement therapy should at least be considered for an exception to the federal ban on human gene editing.

This is a part of the April 2019 CHR VOICE.

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

 


We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS

 

You Might Also Enjoy...

The March/April Voice

Every issue of the VOICE slowly drifts towards more professional subjects, peaking with the literature review, which, primarily addresses physicians and scientists.
IVF in Alabama - What To Do Next?

IVF in Alabama - What To Do Next?

CHR offers the safe transfer of existing frozen embryos into our facility, ensuring continuity of care for patients affected by the suspension of IVF services in Alabama.

Should I Get an AMH Test?

Testing your anti-Mullerian hormone (AMH) levels can provide a lot of information about your ovarian reserve. Find out if you’d be a good candidate for an AMH test here.